Enterprenuers
Cramer’s lightning round: Can’t recommend ChargePoint because it’s unprofitable
[ad_1]
[ad_2]
Veru: “No, [I don’t think Veru shares will increase as much as Moderna’s did if Veru’s Covid treatment receives emergency use clearance]. I think Veru also needs to have that expanded needs of breast cancer, too.”
ChargePoint: “It’s the best one of a bad neighborhood, though. … Here’s the problem: ChargePoint is not making money and we can’t recommend stocks that aren’t making money in this environment. It’s too hard.”
Jackson Financial: “I like that call. I like that call. Nice yield. Annuities [are a] good business.”
Share this news on your Fb,Twitter and Whatsapp
Times News Network:Latest News Headlines
Times News Network||Health||New York||USA News||Technology||World News